Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1993-12-21
pubmed:abstractText
The objectives of this study were to investigate the effects of exogenous somatotropin on growth performance and carcass traits and on concentrations of somatotropin (ST), IGF-I, insulin, glucagon, free fatty acids (FFA), and glucose in plasma of finishing Simmental beef heifers. Three treatment groups, which included 12 heifers each, received a subcutaneous injection of a slowly released recombinant bovine somatotropin (rbST) at two doses (320 and 640 mg, respectively) or a placebo at 2-wk intervals. Treatments began at an average BW of 286 kg and continued until the animals were slaughtered at approximately 520 kg. Heifers had ad libitum access to corn silage and received 1.8 kg/d of concentrate. A before-feeding blood sample was collected from the jugular vein immediately before and 1 wk after each injection during treatment. Treatment tended to increase ADG and to reduce energy consumption per kilogram of gain, whereas feed and energy intake were not altered. Dressing percentage and conformation did not seem to be affected by treatment. Treatment led to a dose-dependent reduction of fat tissue in carcass as well as in kidney fat and to a simultaneous increase of lean tissue (P < .05). Furthermore, treatment caused moderate increases of ST in both treated groups, whereas IGF-I concentrations increased markedly soon after the beginning of the treatment. Insulin and FFA concentrations were elevated in treated groups compared with controls. Glucagon concentrations were not altered by treatment. Effects on growth performance and carcass characteristics are discussed in view of metabolic and endocrine changes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-8812
pubmed:author
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2721-31
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8226373-Adipose Tissue, pubmed-meshheading:8226373-Animals, pubmed-meshheading:8226373-Blood Glucose, pubmed-meshheading:8226373-Body Composition, pubmed-meshheading:8226373-Cattle, pubmed-meshheading:8226373-Dose-Response Relationship, Drug, pubmed-meshheading:8226373-Eating, pubmed-meshheading:8226373-Energy Intake, pubmed-meshheading:8226373-Fatty Acids, Nonesterified, pubmed-meshheading:8226373-Female, pubmed-meshheading:8226373-Glucagon, pubmed-meshheading:8226373-Growth Hormone, pubmed-meshheading:8226373-Injections, Subcutaneous, pubmed-meshheading:8226373-Insulin, pubmed-meshheading:8226373-Insulin-Like Growth Factor I, pubmed-meshheading:8226373-Least-Squares Analysis, pubmed-meshheading:8226373-Meat, pubmed-meshheading:8226373-Muscle Development, pubmed-meshheading:8226373-Muscles, pubmed-meshheading:8226373-Recombinant Proteins, pubmed-meshheading:8226373-Weight Gain
pubmed:year
1993
pubmed:articleTitle
Effects of somatotropin treatment on growth performance, carcass traits, and the endocrine system in finishing beef heifers.
pubmed:affiliation
Institute of Nutrition Physiology, Technical University Munich, Freising-Weihenstephan, FRG.
pubmed:publicationType
Journal Article